484 related articles for article (PubMed ID: 12038157)
1. Student rally. Med school attendees write ethics code on drug firms.
Romano M
Mod Healthc; 2002 May; 32(19):24, 26. PubMed ID: 12038157
[No Abstract] [Full Text] [Related]
2. CMA guidelines on MD-drug industry relations part of international trend.
Williams JR
CMAJ; 1992 Feb; 146(3):386-8. PubMed ID: 11654902
[No Abstract] [Full Text] [Related]
3. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
Barton L
J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
[TBL] [Abstract][Full Text] [Related]
4. AMA fiasco leaves docs with mixed reactions.
Gardner J
Mod Healthc; 1997 Sep; 27(39):15. PubMed ID: 10173609
[No Abstract] [Full Text] [Related]
5. Physician-drug company conflict of interest.
Patterson WB; Emanuel EJ
J Clin Oncol; 1996 Jan; 14(1):316-20. PubMed ID: 8558213
[No Abstract] [Full Text] [Related]
6. AAFP Congress approves statement on ethics of proprietary relationships.
Am Fam Physician; 1991 Dec; 44(6):2233-9. PubMed ID: 1746398
[No Abstract] [Full Text] [Related]
7. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
Blehart B
J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
[No Abstract] [Full Text] [Related]
8. The economic wisdom of regulating pharmaceutical "freebies".
Fisher SH
Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416
[No Abstract] [Full Text] [Related]
9. Doctors and drug companies: the beauty and the beast?
Guömundsson S
Acta Ophthalmol Scand; 2005 Aug; 83(4):407-8. PubMed ID: 16029261
[No Abstract] [Full Text] [Related]
10. Guidelines on gifts to physicians from industry: an update.
Council on Ethical and Judicial Affairs of the American Medical Association
Food Drug Law J; 2001; 56(1):27-40. PubMed ID: 11942349
[No Abstract] [Full Text] [Related]
11. Drug marketing practices criticized.
Wagner L
Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088
[No Abstract] [Full Text] [Related]
12. Proposed guidelines for speakers discussing medications and other products.
Daniel CR; Elewski BE; Scher RK
Cutis; 1997 May; 59(5):271-2. PubMed ID: 9169269
[No Abstract] [Full Text] [Related]
13. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
Rapp MS; Woollard R
CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
[No Abstract] [Full Text] [Related]
14. Guidelines on gifts to physicians from industry: an update.
American Medical Association. Council on Ethical and Judicial Affairs
Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
[No Abstract] [Full Text] [Related]
15. Pharmaceutical companies and our education.
Watkins C
Md Med; 2001; 2(3):22-3, 38. PubMed ID: 11525146
[No Abstract] [Full Text] [Related]
16. AMA prepares report. Local chapters seek further investigation into Sunbeam deal.
Gardner J
Mod Healthc; 1997 Sep; 27(39):14. PubMed ID: 10173608
[No Abstract] [Full Text] [Related]
17. Physician advertising.
Lober CW
Dermatol Clin; 1993 Apr; 11(2):281-4. PubMed ID: 8477539
[TBL] [Abstract][Full Text] [Related]
18. Physician-industry interactions: there is no such thing as a free lunch.
Tsai HJ
Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
[No Abstract] [Full Text] [Related]
19. Tough enough? Rules about drug firms' gifts get new look from docs.
Romano M
Mod Healthc; 2004 Jul; 34(27):16. PubMed ID: 15279115
[No Abstract] [Full Text] [Related]
20. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
Wofford JL; Ohl CA
BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
